Nicolas Bertrand

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)

Nicolas Bertrand, P. Guerreschi, Nicole Basset‐Séguin et al. · EClinicalMedicine · 2021 · 92 citations · Full text

Medicine, Dermatology, Oncology +14

External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer

Vincent Bourbonne, Georges Fournier, Martin Vallières et al. · Cancers · 2020 · 85 citations · Full text

Medicine, Oncology, Radiology +17

Paracetamol: a haemorrhagic risk factor in patients on warfarin

Isabelle Mahé, Nicolas Bertrand, Ludovic Drouet et al. · British Journal of Clinical Pharmacology · 2005 · 66 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer

Émilie Le Rhun, Nicolas Bertrand, Aurélie Dumont et al. · European Journal of Cancer · 2017 · 40 citations · Full text

Medicine, Genetics, Oncology +17

Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients

Fahed Zaïri, Émilie Le Rhun, Nicolas Bertrand et al. · Journal of Neuro-Oncology · 2015 · 40 citations

Medicine, Neurosurgery, Oncology +15